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Abstract The ARGRIII gene of Saccharomyces cerevisiae
encodes a transcriptional regulator that also has inositol
polyphosphate multikinase (ipmk) activity [Saiardi et al. (1999)
Curr. Biol. 9, 1323^1326]. To investigate how inositol phosphates
regulate gene expression, we disrupted the ARGRIII gene. This
mutation impaired nuclear mRNA export, slowed cell growth,
increased cellular [InsP3] 170-fold and decreased [InsP6] 100-
fold, indicating reduced phosphorylation of InsP3 to InsP6.
Levels of diphosphoinositol polyphosphates were decreased much
less dramatically than was InsP6. Low levels of InsP6, and
considerable quantities of Ins(1,3,4,5)P4, were synthesized by an
ipmk-independent route. Transcriptional control by ipmk reflects
that it is a pivotal regulator of nuclear mRNA export via inositol
phosphate metabolism.
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1. Introduction
Several years ago, it was shown that a Saccharomyces ce-
revisiae gene, ARGRIII, controls the transcription of several
enzymes regulating arginine metabolism [1^3]. In addition,
this gene was established to be pleiotropic. This idea recently
returned to prominence with the discovery that the ARGRIII
gene product has inositol polyphosphate multikinase (ipmk)
activity, which can catalyze the ATP-dependent phosphory-
lation of Ins(1,4,5)P3 and Ins(1,3,4,5)P4 [4]. These develop-
ments suggest that inositol phosphates may mediate some of
the functions of ARGRIII that relate to transcriptional regu-
lation.
Another recent study [5] also strongly indicates that there is
a link between the turnover of inositol phosphates and the
regulation of gene expression. In the latter investigation, three
S. cerevisiae genes were identi¢ed which, when deleted, re-
sulted in decreased e⁄ciency of mRNA export from the nu-
cleus via the nuclear pore complex [5]. In one of these mutant
yeast strains, named gsl3, the de¢ciency in mRNA export was
accompanied by a block in the pathway of InsP6 synthesis, at
the stages at which both InsP3 and InsP4 are phosphorylated
[5]. Since the nature of the genetic defect in the gsl3 yeast
strain was not identi¢ed, it was speculated that an essential
regulator of separate InsP3 and InsP4 kinase activities was
compromised [5]. Alternately, it was also pointed out that
the gsl3 strain of yeast might be lacking a single, bi-functional
kinase activity that phosphorylates both InsP3 and InsP4 [5].
We have now pursued the possibility that a loss of the
Ins(1,4,5)P3 and Ins(1,3,4,5)P4 kinase activities of ipmk could
account for the metabolic defect in the gsl3 strain. We also
sought more information concerning the role of the ipmk
protein in this newly emerging relationship between inositol
phosphate turnover and control over gene expression. By cre-
ating and studying a strain of S. cerevisiae from which the
ARGRIII gene is deleted, we reveal new aspects to inositol
phosphate turnover in yeast, and we show that ipmk activity
regulates nuclear export of mRNA.
2. Materials and methods
2.1. Generation and analysis of ipmkv yeast
The YDR173C open reading frame (ORF) in S. cerevisiae com-
prises the ARGRIII gene that encodes ipmk activity. The entire
ARGRIII gene in S. cerevisiae (strain PJ69-2A), including start and
stop codons, was replaced by the dominant kanr marker gene using
the KanMX4 expression construct as previously described [6]. The
oligonucleotides used for the gene disruption were: 5P-ATGGATA-
TGTGCATACGTGTGCCTAAGTAGAAATTTTTTTCACGCAT-
AGGCCACTAGTGGATCTG-3P and 5P-GTACCATATCCCATAA-
ACAAGGTAAACTTCACCTCTCAATATACAGCTGAAGCTTC-
GTACGC-3P. To con¢rm the correct integration of the marker gene,
diagnostic PCR was performed using the following oligonucleotides:
5P-GATAAAGCCATTGGAGATCC-3P and 5P-AATGCAAACACA-
ATAATACC-3P. The sizes of the diagnostic PCR products derived
from the wild-type and mutant (argRIII: :KanMX4 or ipmkv) strains
were 1.4 and 1.8 kb, respectively, close to the sizes of the ARGRIII
gene (1.3 kb) and the kanr gene (1.7 kb). The structures of the PCR
products were also veri¢ed by direct sequencing.
2.2. Yeast culturing and radiolabeling with [3H]inositol
Yeast cultures were grown in YPD media containing 2% (w/v)
glucose. Duplicate 5 ml cultures were seeded at 3U104 cells/ml,
[3H]inositol (100 WCi/ml, American Radiolabeled Chemicals, MO,
USA) was added, and cells were grown at 23‡C through at least eight
doublings. Cultures were then shifted to 37‡C for an additional 2 h.
108 cells were harvested from each culture, washed twice with ice-cold
water and snap-frozen until lysis. Cell pellets were lysed in 0.2 ml ice-
cold lysis bu¡er (2 M perchloric acid/0.1 mg/ml InsP6/2 mM EDTA)
with two cycles of vigorous bead beating (4 mm glass beads pre-
soaked in lysis bu¡er). Lysates were centrifuged for 5 min at 4‡C
and neutralized [7].
Inositol phosphates were then resolved on two complementary high
performance liquid chromatography (HPLC) systems [8,9]: (i) a Parti-
sphere SAX HPLC column (Krackler Scienti¢c, NC, USA) was eluted
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with a gradient generated by mixing bu¡er A (1 mM Na2EDTA) and
bu¡er B (bu¡er A plus 1.3 M (NH4)2HPO4, pH 3.85, with H3PO4) as
follows: 0^5 min, 0% B; 5^10 min, 0^50% B; 10^60 min, 50^100% B;
60^70 min, 100% B. (ii) a SynChropak Q100 SAX HPLC column
(Thompson Instrument, VA, USA) was eluted with a gradient gener-
ated by mixing bu¡er A (1 mM Na2EDTA) with bu¡er B (bu¡er A
plus 2 M (NH4)H2PO4, pH 3.35, with H3PO4): 0^5 min, 0% B; 5^120
min, 0^65% B.
Inositol phosphates were identi¢ed by their co-elution with the
following authentic standards: [3H]Ins(1,4,5)P3, [3H]Ins(1,3,4,5)P4
and [3H]InsP6 (New England Nuclear), [3H]Ins(1,3,4,5,6)P5 [10],
[3H]Ins(1,2,4,5,6)P5 [11], [3H]PP-InsP5 and [3H][PP]2-InsP4 [12] and
14C-labeled Ins(1,3,4,5)P4, Ins(1,3,4,6)P4, D/L-Ins(1,4,5,6)P4 and Ins-
(1,3,4,5,6)P5 isolated from [14C]inositol-labeled, parotid acinar glands
[13].
2.3. Assay of ipmk activity in vitro
The ORF for ARGRIII that encodes ipmk activity was recovered
from the pCMV-GST vector [4] after digestion with SalI and NotI
restriction enzymes, and subcloned into the SalI and NotI sites of the
pGEX-4T-2 expression vector (Amersham Pharmacia Biotech). The
methods used to transform Escherichia coli (strain BL21), to induce
with IPTG, and to isolate the GST fusion protein using glutathione
Sepharose 4B resin were all according to the manufacturer’s recom-
mendations (Amersham Pharmacia Biotech). Ipmk activity was as-
sayed by incubating the protein for 5^60 min at 37‡C with trace
amounts (10 000 dpm) of the appropriate 3H-labeled inositol phos-
phate in 25 Wl assays containing 20 mM HEPES (pH 7.0), 12 mM
MgSO4, 10 mM Na2ATP, 20 mM phosphocreatine, 1 mM DTT,
1 mM EDTA, 360 U phosphocreatine kinase (Calbiochem) and
0.5 mg/ml bovine serum albumin (BSA). Assays were quenched with
PCA, neutralized with KCO3 as described previously [7], and inositol
phosphates were resolved by HPLC (see above).
2.4. Localization of poly(A)+ RNA by in situ hybridization
Early logarithmic phase cultures of yeast were grown at 23‡C before
shifting to 37‡C for 2 h. Cells were harvested and ¢xed for 45 min in
4% formaldehyde in 0.1 M phosphate bu¡er (K salt, pH 6.5) and
washed three times in solution A (1.2 M sorbitol, 0.1 M phosphate
bu¡er (K salt, pH 7.5)). Cells were treated for 45 min at 30‡C in
solution A plus 0.1 mg/ml of lyticase (Sigma); resulting spheroplasts
were washed in solution A and plated onto a polylysine-coated slide
for 45 min at 4‡C. Samples were washed and dehydrated in 70%
EtOH overnight at 320‡C. Samples were treated for hybridization
as previously described [14]. Then, samples were washed three times
in 2USSC at 37‡C for 10 min, and then three times in 1USSC at
room temperature for 10 min. Cells were permeabilized for 5 min at
room temperature in solution B (150 mM NaCl, 100 mM Tris^HCl
pH 7.5) containing 0.1% (v/v) Triton X-100, and then washed in so-
lution B and incubated for 1 h at room temperature with anti-digoxi-
genin-£uorescein Fab fragment (Boehringer Mannheim) in solution B
plus 1% (w/v) BSA. The slides were washed at room temperature in
solution B for 5 min, then washed in solution B containing 100 ng/ml
4P,6-diamidino-2-phenylindole for 10 min, followed by a ¢nal wash in
300 mM NaCl, 100 mM Tris^HCl pH 7.5 for 15 min. Photographs
were taken with a 60U objective on a Zeiss Axioskop microscope
with Kodak Elite 400 ¢lm.
3. Results and discussion
3.1. Analysis of ipmk activity in vitro
Ipmk was recently shown to phosphorylate both Ins-
(1,4,5)P3 and Ins(1,3,4,5)P4, although the products of these
reactions were not characterized [4]. We have now used
HPLC to determine that ipmk catalyzed the phosphorylation
of Ins(1,4,5)P3 at both the 3- and 6-positions, forming Ins-
(1,3,4,5)P4 and Ins(1,4,5,6)P4 (Fig. 1). InsP5 was also formed
(Fig. 1) by further phosphorylation of both InsP4 isomers
(data not shown). This InsP5 was shown to be the 1,3,4,5,6-
isomer; no Ins(1,2,4,5,6)P5 was formed (data not shown). The
fact that Ins(1,4,5)P3 is phosphorylated to Ins(1,4,5,6)P4 by
ipmk (which is 40 kDa [4]) suggests ipmk is equivalent to the
Ins(1,4,5)P3 6-kinase activity of a 40 kDa protein that was
partly puri¢ed from S. cerevisiae several years ago [15]. The
authors of the latter study found that their preparations
of partly puri¢ed Ins(1,4,5)P3 6-kinase also phosphorylated
Ins(1,4,5,6)P4 to Ins(1,3,4,5,6)P5, but the latter 3-kinase activ-
ity was attributed to a di¡erent, contaminating enzyme [15].
In contrast, our data show it is ipmk that phosphorylates
Fig. 1. Products of Ins(1,4,5)P3 phosphorylation by ipmk in vitro.
[3H]Ins(1,4,5)P3 was incubated for 0 min (open circles) and 10 min
(closed circles) with 2 ng ipmk (see Section 2). Samples were
quenched and neutralized and chromatographed on a SynChropak
Q100 SAX HPLC column (see Section 2); 0.5 ml fractions were col-
lected. The 3H-labeled products, namely, Ins(1,3,4,5)P4, Ins-
(1,4,5,6)P4 and Ins(1,3,4,5,6)P5, were all identi¢ed by their co-elu-
tion with internal 14C-labeled standards (squares) of these three
compounds. The elution position of InsP6 is also indicated by an
arrow. Data are representative of three experiments.
Table 1
Levels of inositol phosphates in wild-type and ipmkv yeast
DPM in wild-type DPM in ipmkv ipmkv/wild-type
InsP2 3 447 þ 571 248 502 þ 43 908 72
Ins(1,4,5)P3 921 þ 178 159 709 þ 11 642 173
Ins(1,4,5,6)P4 349 þ 38 0 ^
Ins(1,3,4,5)P4 0 6 046 þ 316 ^
X 490 þ 161 1 659 þ 582 3.4
Ins(1,3,4,5,6)P5 1 104 þ 300 159 þ 48 0.14
D/L-Ins(1,2,3,4,5)P5 148 þ 23 2 724 þ 631 18.4
D/L-Ins(1,2,4,5,6)P5 2 750 þ 852 0 ^
InsP6 56 167 þ 7 502 519 þ 106 0.009
PP-InsP5 420 þ 78 133 þ 22 0.32
[PP]2-InsP4 460 þ 53 65 þ 48 0.14
Data (mean þ S.E.M.) are taken from three experiments similar to those described in Fig. 2.
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Ins(1,4,5,6)P4 to Ins(1,3,4,5,6)P5 (Fig. 1). Ipmk is also prob-
ably very similar to a 41 kDa kinase puri¢ed from Schizo-
saccharomyces pombe that phosphorylates Ins(1,4,5)P3 to Ins-
(1,3,4,5,6)P5, via Ins(1,4,5,6)P4 and Ins(1,3,4,5)P4 [16].
3.2. The inositol phosphate pro¢le in wild-type and ipmkv
strains of S. cerevisiae
The inositol phosphate pro¢les of the wild-type and ipmkv
strains were compared. A major di¡erence was the accumu-
lation of large quantities of Ins(1,4,5)P3 in the mutant strain,
to levels that were 173-fold above those of the wild-type (Fig.
2; Table 1). Ins(1,4,5)P3 accumulated because it continued to
be produced from the yeast’s ongoing PLC activity [5], but it
was no longer phosphorylated by ipmk. The ipmkv yeast also
had 72-fold higher levels of InsP2 than did the wild-type (Fig.
2, Table 1), presumably re£ecting some dephosphorylation of
the excess Ins(1,4,5)P3. In yeasts, Ins(1,4,5)P3 has been pro-
posed to be a precursor for the synthesis of InsP5 and InsP6
[5,16]. This hypothesis is supported by the observations that,
relative to the wild-type yeast, the ipmkv strain contained 100-
fold lower levels of InsP6, and at least 10-fold lower levels of
D/L-Ins(1,2,4,5,6)P5 and Ins(1,3,4,5,6)P5 (Fig. 2).
The pro¢le of [3H]InsP4 isomers was altered in the ipmkv
yeast. Wild-type cells contained two InsP4 peaks. One of
these, which was not identi¢ed (peak ‘X’), eluted between
standards of Ins(1,3,4,6)P4 and Ins(1,3,4,5)P4 on a SynChro-
pak SAX HPLC column (Fig. 3A). The other InsP4 co-eluted
with Ins(1,4,5,6)P4 (Fig. 3A). In contrast, Ins(1,4,5,6)P4 was
absent in the ipmkv strain (Fig. 3B), due to the elimination of
the Ins(1,4,5)P3 6-kinase activity of ipmk. In addition, the
ipmkv cells were found to contain considerable quantities of
another InsP4 isomer, namely Ins(1,3,4,5)P4 (on the Synchro-
pak HPLC column, Ins(1,3,4,5)P4 was contaminated with
peak ’X’ (Fig. 3B), but these two compounds were resolved
when cell extracts were analyzed with a Partisphere SAX col-
umn (Fig. 2B)). Since Ins(1,3,4,5)P4 was not detected in wild-
type yeast (Fig. 3A), there is a dramatic up-regulation of
Ins(1,3,4,5)P4 levels in the absence of InsP3 phosphorylation
Fig. 2. Partisphere SAX HPLC analysis of inositol phosphates in
wild-type and ipmkv yeast. [3H]Inositol phosphates were resolved
from [3H]inositol-labeled wild-type (A) and ipmkv cells (B), using a
Partisphere SAX column (see Section 2); 1 ml fractions were col-
lected. The inset to each panel shows the same data using a di¡er-
ent y-axis scale. The structures of several inositol phosphates (Ins-
(1,4,5)P3, Ins(1,3,4,5,6)P5, D/L-Ins(1,2,3,5,6)P5, InsP6, PP-InsP5 and
[PP]2-InsP4) were assigned from their elution times matching those
of corresponding, authentic 3H-labeled standards, which were sepa-
rately determined in parallel HPLC runs. The D/L-Ins(1,2,3,5,6)P5
was tentatively identi¢ed from its known [8] elution position be-
tween Ins(1,3,4,5,6)P5 and D/L-Ins(1,2,4,5,6)P5. The identi¢cation of
Ins(1,3,4,5)P4 and Ins(1,4,5,6)P4 is described by Fig. 3. Peak ‘X’
was not identi¢ed. Data are representative of three experiments.
Fig. 3. SynChropak Q100 SAX HPLC analysis of inositol phos-
phates in wild-type and ipmkv yeast. [3H]InsP4 isomers (¢lled
circles) from wild-type (A) and ipmkv cells (B) were resolved using
a SynChropak Q100 SAX column (see Section 2); 0.5 ml fractions
were collected. Elution positions of authentic 14C-labeled internal
standards (open circles) of Ins(1,3,4,5)P4, Ins(1,3,4,6)P4 and Ins-
(1,4,5,6)P4 are marked. In extracts prepared from wild-type cells
(A), two 3H-labeled InsP4 isomers were observed. One co-eluted
with [14C]Ins(1,4,5,6)P4 and the other (corresponding to peak ’X’ in
Fig. 2) eluted between standards of Ins(1,3,4,6)P4 and Ins(1,3,4,5)P4.
In extracts prepared from ipmkv cells, one 3H-labeled peak co-
eluted with a standard of [14C]Ins(1,3,4,5)P4. Note that this Syn-
Chropak HPLC column does not resolve Ins(1,3,4,5)P4 from the
minor, contaminating peak ‘X’. These two peaks were, however,
separated on a Partisphere SAX column (Fig. 2). Data are represen-
tative of three independent experiments. Absolute elution times dif-
fer in A and B because of batch variation in the two Synchropak
columns that were used for these experiments.
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by ipmk. Thus, S. cerevisiae synthesizes Ins(1,3,4,5)P4 using
a di¡erent inositol phosphate kinase that by-passes ipmk.
Furthermore, the persistence of low levels of InsP6 in the
ipmkv yeast suggests that, to a limited extent, this auxiliary
metabolic pathway extends to the synthesis of InsP6. D/L-
Ins(1,2,3,4,5)P5 might participate in this alternate metabolic
route, since its levels increased 18-fold in the ipmkv cells (Ta-
ble 1). It has previously not been considered that there might
be more than one pathway of InsP6 synthesis in yeast.
We also identi¢ed both PP-InsP5 and [PP]2-InsP4 in S. ce-
revisiae (Fig. 1). In mammalian cells, these ‘high-energy’ di-
phosphoinositol polyphosphates are candidate molecular
switches [17,18] that are rapidly metabolized through sub-
strate cycles that are regulated by cAMP, cGMP and Ca2
[8,19]. PP-InsP5 and [PP]2-InsP4 are present at 100-fold lower
levels than InsP6, as is the case in higher eukaryotes [17]. This
is the ¢rst time that PP-InsP5 and [PP]2-InsP4 have been iden-
ti¢ed in any yeast, although their presence was anticipated,
following earlier identi¢cation of a kinase from S. cerevisiae
that synthesizes PP-InsP5 [4] and the discovery of a diphos-
phoinositol polyphosphate phosphatase from the same organ-
ism [12].
It should be noted that the ipmkv strain of yeast grew more
slowly than the wild-type at both 23‡C and 30‡C, and growth
was completely arrested at 37‡C ([2] and data not shown).
Despite this temperature-sensitive growth phenotype, all of
the di¡erences in the inositol phosphate pro¢le between
wild-type and ipmkv yeast strains that were observed at
37‡C (Figs. 2 and 3) were also observed at 23‡C (data not
shown).
3.3. Inositol phosphates and the regulation of nuclear mRNA
export
Recently, York et al. [5] described a mutant strain of yeast,
named gsl3, that displayed changes in inositol phosphate turn-
over that, in some cases, are similar to those of our ipmkv
strain. These include decreases in levels of InsP6, accompanied
by increases in levels of InsP2, Ins(1,4,5)P3 and InsP4 [5]. The
protein product that was disrupted in the gsl3 strain was not
identi¢ed, although it was suggested that it might be either (i)
a regulator of kinase activities against InsP3 and InsP4, or (ii)
a multifunctional InsP3/InsP4 kinase [5]. Our data indicate for
the ¢rst time that deletion of a genuine InsP3/InsP4 kinase
does promote the changes in inositol phosphate turnover
that typi¢ed the gsl3 strain [5]. Thus, our data are consistent
with the gsl3 strain being equivalent, and probably identical,
to the ipmkv strain. York et al. [5] reported that the gsl3
variant was one of three yeast strains displaying impaired
mRNA export from the nucleus. Thus, it was important to
determine if mRNA export was also inhibited in our own
ipmkv mutant.
Poly(A) RNA was detected with a £uorescein isothiocya-
nate-coupled antibody against digoxigenin. In wild-type cells,
a di¡use signal was distributed throughout the cell (Fig. 4).
However, the ipmkv cells contained more punctate signals
that were restricted to the nuclei, as revealed by coincident
staining with 4P,6P-diamidino-2-phenylindole (Fig. 4). These
results are consistent with mRNA export from the nucleus
being strongly impaired in the ipmkv yeast, although we can-
not exclude the possibility that there may also be some de-
creased stability of cytoplasmic mRNA. mRNA export itself
comprises a series of molecular events including RNA syn-
thesis, polyadenylation and capping, ribonucleoprotein target-
ing to the pore complex as well as transport through it [20]. A
defect in any of these individual steps could account for the
loss of cytoplasmic poly(A) in the ipmkv cells (Fig. 4).
Ipmk was ¢rst discovered as a product of the ARGRIII
gene [4], which controls the transcription of enzymes involved
in arginine metabolism [1^3]. The latter workers have also
indicated that ARGRIII is pleiotropic, although it was unclear
what molecular mechanisms underlie the additional gene func-
tions [2]. Therefore, our demonstration that disruption of this
same gene both a¡ects mRNA dynamics and causes global
changes in inositol phosphate turnover represents major ¢nd-
ings in our study.
How might these changes in inositol phosphate turnover
regulate nuclear mRNA export in yeast? [InsP6] may be one
factor that is important; other genetic mutations in S. cerevi-
siae that also impaired mRNA export, namely, deletion of
either the Ins(1,3,4,5,6)P5 2-kinase or PLC, both have in com-
mon with the ipmkv cells a dramatic decrease in InsP6 levels
[5]. However, our results indicate that it may be an over-sim-
pli¢cation to attribute a reduced rate of mRNA export to a
decrease in [InsP6], in part because we have shown that InsP6
does not represent a metabolic end-point in yeast. The
concentrations of two InsP6 metabolites, namely, PP-InsP5
and [PP]2-InsP4, also decrease in the ipmkv yeast (Table 1).
Moreover, the ipmkv cells also have substantial increases in
levels of D/L-Ins(1,2,3,4,5)P5, Ins(1,3,4,5)P4 and Ins(1,4,5)P3,
as well as decreased concentrations of Ins(1,4,5,6)P4 and
D/L-Ins(1,2,4,5,6)P5 (Table 1). It could be that one or more
of these other polyphosphates, rather than InsP6 itself, are the
compounds that play an important role in mRNA export. In
particular, it is notable that the turnover of the diphospho-
inositol phosphates is generally a rapid, ongoing activity that
demands a considerable investment of cellular energy [17];
nuclear mRNA export is also an energy-intensive process
[20]. In any case, the particular importance to the yeast cell
of PP-InsP5 and [PP]2-InsP4 is indicated by the fact that, in
Fig. 4. Nuclear mRNA export in wild-type and ipmkv yeast. The
upper panels show poly(A) RNA labeling. The lower panels show
the same ¢elds processed for DAPI staining. Data are representative
of three experiments.
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the face of 100-fold decreases in the levels of InsP6, the yeast
cells apparently change the poise of the kinase/phosphatase
substrate cycles that turn over these diphosphoinositol poly-
phosphates; thus, the ratio of PP-InsP5 :InsP6 increased nearly
40-fold, from a value of 0.007 in the wild-type cells to 0.26 in
the ipmkv yeast (Table 1).
Our data establish that complex changes in inositol phos-
phate metabolism are associated with decreased e⁄ciency of
nuclear export of mRNA. Analysis of signal transduction by
inositol phosphates in the nuclei or at the level of the nuclear
pore complex may elucidate the mechanism of nuclear mRNA
transport at the molecular level.
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